http://www.fda.gov/cder/orange/appendix_a.txt
4, ACETAMINOPHEN TYLENOL W/ CODEINE, ACETAMINOPHEN TYLENOL, ACETAMINOPHEN (OTC) TYLOX, ACETAMINOPHEN TYLOX-325, ACETAMINOPHEN TYMTRAN, CERULETIDE DIETHYLAMINE TYZINE, TETRAHYDROZOLINE HYDROCHLORIDE TZ-3, TIOCONAZOLE (OTC) ** U ** U-CORT, HYDROCORTISONE ACETATE U-GENCIN, GENTAMICIN SULFATE UCEPHAN, SODIUM BENZOATE ULO, CHLOPHEDIANOL HYDROCHLORIDE ULTANE, SEVOFLURANE ULTIVA,...
Prescription and Over-the-Counter Drug Product List: 8/2003
4 >D> AA + ORTHO MCNEIL PHARM 300MG;60MG N85055 004 AUG DISC >A> @ 300MG;60MG N85055 004 AUG DISC ACETAMINOPHEN; HYDROCODONE BITARTRATE SOLUTION; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >A> AA + MALLINCKRODT 500MG/15ML;10MG/15ML N40508 001 AUG 29, 2003 AUG NEWA >D> MIKART 500MG/15ML;5MG/15ML N81226 001 OCT 27, 1992 AUG CTEC >A> AA 500MG/15ML;5MG/15ML N81226 001 OCT 27, 1992 AUG...
author: AUTHOR
OGD, First Time Approvals - May 2002
Food and Drug Administration Center for Drug Evaluation and Research Drug Information Search First-Time Generics - May 2002 Generic Drug Name Generic Manufacturer Brand Name Approval Date 1- IDARUBICIN HYDROCHLORIDE FOR INJECTION, USP 5 MG, 10 MG, AND 20 MG SINGLE-DOSE VIALS GENSIA SICOR PHARMACEUTICALS, INC IDAMYCIN PFS INJECTION 5/1/02 4- CYCLOSPORINE CAPSULES, USP 25 MG...
author: OGD
50675S14_Vantin.htm
Food and Drug Administration Center for Drug Evaluation and Research Approval Package Search Vantin (Cefpodoxime Proxetil) Oral Suspension Company:- Pharmacia & Upjohn Application No.:- 50-675/S014 Approval Date:-11/20/1998 - Approval Letter(s) - Medical Review(s)- - Part 1 - Part 2 - Statistical Review(s) Microbiology Review(s) - Clinical Pharmacology...
author: Paul Stauffer
http://www.fda.gov/cder/ogd/rld/RLD_LABELING_APPROVED_NOV_1998.HTML
Firm Date PHENDIMETRAZINE TARTRATE CAPSULE Phendimetrazine Tartrate Capsule 18-074 S-028 Eon 3-Nov-1998 BUTISOL SODIUM Butabarbital Sodium Tablet 00-793 S-015 Wallace 4-Nov-1998 HYDRODIURIL Hydrochlorothiazide Tablet 11-835 S-060 Merck 5-Nov-1998 ATROVENT MDI Ipratropium Bromide 20-394 S-001 Boehringer-Ingelheim 9-Nov-1998 PEPCID AC Famotidine Tablet 20-325 S-007 Merck 9-Nov-1998...
Prescription and OTC Drug Product List 5/2002
2 -D- + ROBINS AH 325MG;15MG N84444 001 MAY DISC -A- @ 325MG;15MG N84444 001 MAY DISC SOLUTION; ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE -D- AA ALPHARMA 120MG/5ML;12MG/5ML N85861 001 MAY CRLD -A- AA + 120MG/5ML;12MG/5ML N85861 001 MAY CRLD TYLENOL W/ CODEINE -D- AA + JOHNSON RW 120MG/5ML;12MG/5ML N85057 001 MAY DISC -A- @ 120MG/5ML;12MG/5ML N85057 001 MAY DISC TABLET; ORAL...
ranbaxy
- - - - -- You are here :- Home - News Room - June 2002 Ranbaxy receives US FDA approval for the Manufacturing and Marketing of Cefpodoxime Proxetil Suspension New Delhi, June 04, 2002 Ranbaxy Pharmaceuticals ...
ranbaxy
- - - - -- - You are here :- Home - News Room - June 2002 Ranbaxy receives US FDA approval for the Manufacturing and Marketing of Cefpodoxime Proxetil Suspension New Delhi, June 04, 2002 Ranbaxy ...
FDA Drug Approvals List
Active Ingredient(s): NEDOCROMIL SODIUM OTC/RX Status: RX Efficacy Claim: Extending the approved use to the pediatric population of 6-11 years of age Approvable Original New Drug Applications Original Application #: 019781 Approvable Date: 31-MAR-97 Trade Name: PROMETRIUM Dosage Form: CAPSULE Applicant: SCHERING PLOUGH CORP Active Ingredient(s): PROGESTERONE OTC/RX Status: RX...
FDA Drug Approvals List- November 1998
Drug Approvals for November 1998 Definitions and Notes November 1998 Original New Drug Applications Original Application #: 021008 Approval Date: 25-NOV-98 Trade Name: SANDOSTATIN LAR Chemical Type: 3 Therapeutic Potential: P Dosage Form: INJECTABLE Applicant: NOVARTIS PHARMACEUTICALS CORP DBA SANDOZ PHARMACEUTICALS CORP Active Ingredient(s): OCTREOTIDE ACETATE OTC/RX Status: RX...
DDPA June 1995
74-423 CAPTOPRIL MOVA CAPTOPRIL 07-JUN-95 (TABLET) CAGUAS, PR 12.5MG 00725 25MG 50MG 100MG (ANGIOTENSIN CONVERTING ENZYME INHIBITOR) ***LABELING SUPPLEMENTS TO ORIGINAL NDAs*** 17-911 CLINORIL MERCK SULINDAC 01-JUN-95 (TABLET) WEST POINT, PA 150MG 19486 200MG (LABELING REVISION -- PRECAUTIONS; ADVERSE REACTIONS) 16-744* NORIDAY 1+50-FE SYNTEX FERROUS FUMARATE 02-JUN-95 (TABLET) PALO...
DDPA May 1996
Drug and Device Product Approvals for May 1996 ***ORIGINAL AND SUPPLEMENTAL NDAs*** FOR NEW DRUG PRODUCTS 16-191 SORBITRATE ZENECA ISOSORBIDE DINITRATE 01-APR-96 (TABLET, SUBLINGUAL) WILMINGTON, DE 2.5MG (SUPPL-033) 19850 5MG (VASODILATOR) [MET CONDITIONS FOR APPROVAL PER FEDERAL REGISTER NOTICE OF AUGUST 3, 1984 (49 FR 31151)] 16-192 SORBITRATE ZENECA ISOSORBIDE DINITRATE 01-APR-96 ...
DDPA March 1996
74-488 RANITIDINE HCL GRANUTEC RANITIDINE HYDROCHLORIDE 05-MAR-96 (TABLET) WILSON, NC EQ 150MG BASE 27896 EQ 300MG BASE (HISTAMINE H-2 RECEPTOR ANTAGONIST) ***LABELING SUPPLEMENTS TO ORIGINAL NDAs*** 04-570 HEPARIN SODIUM UPJOHN HEPARIN SODIUM 04-MAR-96 (INJECTABLE) KALAMAZOO, MI 1,000 UNITS/ML 49001 5,000 UNITS/ML 10,000 UNITS/ML (LABELING REVISION -- WARNINGS; PRECAUTIONS; ADVERSE...
DDPA February 1996
THERE ARE NO ORIGINAL ABBREVIATED AND 505(b)(2) NDAs WITH TENTATIVE APPROVALS FOR FEBRUARY 1996 ***LABELING SUPPLEMENTS TO ORIGINAL NDAs*** 20-123 OMNIS CAN NYCOMED GADODIAMIDE 05-FEB-96 (INJECTABLE) WAYNE, PA 287MG/ML 19087 (LABELING REVISION -- INDICATIONS AND USAGE; DOSAGE AND ADMINISTRATION) 19-099 DOPAMINE HCL AND MCGAW DOPAMINE HYDROCHLORIDE 07-FEB-96 DEXTROSE 5% IRVINE, CA...
Antibiotics for sinusitis - [Medication] - Quest Diagnostics Patient Health Library
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Antibiotics for sinusitis - [Medication] - Quest Diagnostics Patient Health Library Antibiotics for sinusitis - [Medication] - Quest Diagnostics Patient Health Library Amoxicillin, amoxicillin with clavulanate, amoxicillin with clavulanate potassium,...
Antibiotics for urinary tract infections in children - [Medication] - Quest Diagnostics Patient Health Library
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Antibiotics for urinary tract infections in children - [Medication] - Quest Diagnostics Patient Health Library Antibiotics for urinary tract infections in children - [Medication] - Quest Diagnostics Patient Health Library Children’s health, Infant and...
Antibiotics for sinusitis - [Medication] - Quest Diagnostics Patient Health Library
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Antibiotics for sinusitis - [Medication] - Quest Diagnostics Patient Health Library Antibiotics for sinusitis - [Medication] - Quest Diagnostics Patient Health Library Amoxicillin, amoxicillin with clavulanate, amoxicillin with clavulanate potassium,...
Antibiotics for middle ear infection - [Medication] - Quest Diagnostics Patient Health Library
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Antibiotics for middle ear infection - [Medication] - Quest Diagnostics Patient Health Library Antibiotics for middle ear infection - [Medication] - Quest Diagnostics Patient Health Library Children’s health, Ear, nose, and throat, Infant and toddler...
H:F74S12.PDF
NDA 50- 674/ S- 012 NDA 50- 675/ S- 015 Pharmacia & Upjohn Attention: Rebecca S Tong: Please refer to your supplemental new drug applications dated January 20, 1998, received January 22, 1998, submitted under section 505( b) of the Federal Food, Drug, and Cosmetic Act for Vantin ® (cefpodoxime proxetil) Tablets and Vantin ® (cefpodoxime proxetil) ...
author: Unknown
H:F74S12.PDF page 1
author: Unknown
H:F75S14.PDF
NDA 50- 675/ S- 014 Pharmacia & Upjohn Attention: Rebecca S Tong: Please refer to your supplemental new drug application dated December 19, 1997, received December 22, 1997, submitted under section 505( b) of the Federal Food, Drug, and Cosmetic Act for Vantin ® (cefpodoxime proxetil) Oral Suspension We note that this application is subject to the exemption...
author: Unknown
H:F75S14.PDF page 1
author: Unknown
http://www.biosis.org/ts/media/cdjournals/gazettenews/2002/CPG_News_0243.pdf
week 0243 25 October 2002 Wyeth has nine applications claiming bi- and tricyclic (di)azepine carboxamides as oxytocin/vasopressin antagonists, continuing the seires from which WAY-VNA-932 has been selected for preclinical studies (see page 21) ISSN:1464-3499 Drug Patenting in Context US authorities to market its 10 mg and 20 mg omeprazole capsules. Final FDA approval will be given...
Gazette Highlights News 2002 - Thomson Scientific
Thomson.com - - - - - Advanced Search - - - EN : JP : CN : KR -- - - Thomson Scientific : Gazette Weekly Highlights News : Gazette Highlights News 2002 - Gazette Highlights News 2002 Click on a week to view more Week 52: We wish all readers a happy and successful New Year! The grant of an SPC for NeXstar's DaunoXome (a liposomal formulation of daunorubicin) was announced this week...
Maximum Recommended Therapeutic Dose (MRTD) Database
Maximum Recommended Therapeutic Dose (MRTD) Database (1,235 pharmaceuticals) A -- B- - C -- D -- E -- F-G -- H-K -- L -- M -- N -- O -- P -- Q-R -- S -- T -- U-Z MRTD--- (mg/kg--- bw/day) -- Generic Chemical Name Chemical Structure (SMILES Code) 3.00000-- Acemetacin C1=C(OC)C=C3C(=C1)N(C(=O)C2=CC=C(Cl)C=C2)C(C)=C3CC(=O)OCC(O)=O 0.20000-- Acenocoumarol C1=CC=C3C(=C1)OC(=O)C(C(CC(C)=O...